Coronado Biosciences forms new subsidiary, Checkpoint Therapeutics
Coronado Biosciences announced formation of a subsidiary company, Checkpoint Therapeutics, to develop a portfolio of fully human immuno-oncology targeted antibodies generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a Professor in the Department of Cancer Immunology and AIDS at Dana-Farber. March 04, 2015